MEC Plus Events — 2025 MaTOS Breast 2025 MaTOS GU 2025 MCM 2025 PRIMO 2025 South Florida GI Cancer Symposium 2025 Winter Cancer Symposium (WCS) 2024 Advances in Oncology Conference 2024 Best of WCLC San Francisco 2024 California Cancer Consortium Conference (CCC) 2024 MaTOS Lungs 2024 MCM 2024 MLS Cleveland 2024 MLS Irvine 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PACC Miami 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 Updates in Cancer Therapies 2024 WCS Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignant Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Oral Cancer Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Type of Media — Video Document Audio Author / Speaker Title Search Entries: « 1 … 46 47 48 49 50 … 100 » Update on T-cell Lymphomas Yuliya Linhares, MD View PDF Modern Challenges and New Options for B-cell NHL Eduardo Sotomayor, MD View Video Modern Challenges and New Options for B-cell NHL Eduardo Sotomayor, MD View PDF New Developments in CLL Eduardo Sotomayor, MD View Video New Developments in CLL Eduardo Sotomayor, MD View PDF Most Relevant Data on Immunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC Luis E. Raez, MD, FACP, FCCP View Video Most Relevant Data on Immunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC Luis E. Raez, MD, FACP, FCCP View PDF Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC Stephen Liu, MD View PDF Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC Stephen Liu, MD View Video Advances in Targeted Therapy in Lung Cancer Edgardo S. Santos, MD, FACP View Video Advances in Targeted Therapy in Lung Cancer Edgardo S. Santos, MD, FACP View PDF New Developments in Therapeutics for Metastatic Breast Cancer Helen Chew, MD View Video New Developments in Therapeutics for Metastatic Breast Cancer Helen Chew, MD View PDF Breast Cancer Update in Hormone Sensitive Breast Cancer Ricardo H. Alvarez, MD View Video Breast Cancer Update in Hormone Sensitive Breast Cancer Ricardo H. Alvarez, MD View PDF Novel Frontiers in the Use of ctDNA in Oncology Julia Rotow, MD View Video Novel Frontiers in the Use of ctDNA in Oncology Julia Rotow, MD View PDF Advances in Head and Neck Cancers Including Thyroid malignancies Lori Wirth, MD View Video Advances in Head and Neck Cancers Including Thyroid malignancies Lori Wirth, MD View PDF Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations Mark S, Shahin, MD, FACOG, FACS View Video Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations Mark S, Shahin, MD, FACOG, FACS View PDF Updates in Kidney and Bladder Cancers Jaime Merchan, MD View Video Updates in Kidney and Bladder Cancers Jaime Merchan, MD View PDF Updates in Cholangiocarcinoma and Pancreas Cancer Jaffer A. Ajani, MD View Video Updates in Cholangiocarcinoma and Pancreas Cancer Jaffer A. Ajani, MD View PDF Updates in Colorectal Cancer Ahmed Zakari, MD View Video Updates in Colorectal Cancer Ahmed Zakari, MD View PDF Updates in Prostate Cancer Chandler H. Park, MD, FACP View PDF Updates in Prostate Cancer Chandler H. Park, MD, FACP View Video Mechanism of Resistance to EGFR-ALK & Other Relevant Pathways Julia Rotow, MD View PDF We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
